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INTRODUCTION
Primary brain tumors represent 29% of all childhood cancers, are the most common solid childhood tumor, and are the leading cause of cancer death in this age population [1] . With experienced pediatric neuroimaging specialists, presurgical diagnosis with anatomic MRI sequences can be accurate, especially with a classic appearance and location presentation. However, many primary neoplasms do not follow the classic imaging appearance and the use of advanced imaging techniques such as perfusion imaging, diffusion weighted imaging, and MR spectroscopy have been utilized to grade primary pediatric tumors [2] [3] [4] .
Dynamic susceptibility contrast (DSC) perfusion MRI has demonstrated utility in the pretreatment evaluation of adult intracranial neoplasms for tumor grading, guiding biopsy, and prognosis. However, while the most common adult primary parenchymal neoplasms are of the astrocytic cell type, the most common pediatric primary brain tumors have diverse cellular origins, with astrocytic origin for pilocytic astrocytomas and embryonal neuroepithelial origin for medulloblastomas. Even within astrocytomas, outside of the classic "cyst and mural nodule" appearance of pilocytic astrocytomas, there is some overlap in the radiographic and histological appearance of pilocytic astrocytomas and high grade gliomas, with relative cerebral volume (rCBV) demonstrating usefulness in distinguishing the two astrocytic entities [5] . However, when the most common pediatric primary brain tumors are evaluated, there is an overlapping range of rCBV values, particularly between pilocytic astrocytomas and medulloblastomas, limiting the usefulness of DSC perfusion in predicting low versus high grade tumors preoperatively [2] .
While rCBV has received the greatest attention in differentiating tumor grades from perfusion imaging in adult tumors [6] [7] [8] , tissue signal intensity time curves (TSITC) have also demonstrated diagnostic utility, most notably in differentiating primary CNS lymphoma from glioblastoma multiforme and metastases [9] [10] [11] . We evaluate the inter-observer agreement of classification of DSC perfusion MRI TSITCs and the utility of curve classification as a tool for grading pediatric brain tumors.
MATERIALS AND METHODS
Following institutional review board approval, a retrospective radiology database search from September 2009 to August 2013 identified a total of 65 pediatric brain tumor patients with pathology-proven diagnosis and assigned World Health Organization (WHO) grade who had undergone DSC perfusion MRI on initial evaluation prior to chemotherapy, biopsy or surgical resection. In the majority of cases, a single dose of 2mg/kg IV dexamethasone was given emergently prior to MRI for the treatment of tumor associated cerebral edema. A total of two cases were excluded for a total of 63 cases for review. One case was excluded due to poor contrast bolus and the second case was excluded due to significant susceptibility artifact generated by the patient's dental braces. This study population was previously reported [2] .
MR Imaging
DSC perfusion MR images were obtained during the first pass of a bolus of gadobenate dimeglumine (MultiHance, Bracco Diagnostics Inc., Princeton, NJ) on 1.5T and 3T MRI scanners (Siemens Avanto and Verio, Erlangen, Germany) using a gradient echo echo planar sequence (TR 1410-2250 / TE 30 and 45 ms, flip angle 90 degrees). Two different TEs were utilized on different scanners. A range of TR was adjusted for tumor coverage. No cases were performed with a preload of IV contrast. Following a pre-contrast phase to establish a baseline, a contrast medium dose of 0.1 mmol/kg of body weight was injected followed by a normal saline flush for a total volume of 32 ml. When possible, an 18 or 20 gauge peripheral intravenous access was used with a power injector rate of 5 ml/s. In some cases, primarily with smaller children, only 24 gauge peripheral intravenous access was possible. Contrast bolus adequacy was evaluated by two fellowship-trained board-certified neuroradiologists with certificate of added qualification (C.H., 7 years experience, and S.K., 3 years experience) based on TSITCs and included or excluded in consensus.
Data Analysis
Using a commercially available workstation (Dynasuite Neuro 3.0, InVivo Corp, Pewaukee WI), each neuroradiologist independently selected multiple 3 to 5 mm 2 ROIs within the tumor, placed at the locations of perceived highest rCBV using Dynasuite-generated rCBV maps, blinded to pathologic diagnosis. Anatomic MR imaging sequences were used to help define tumor location and avoid major blood vessels or hemorrhage when placing the ROI. The resulting signal intensity curve from the ROI with the highest rCBV was used for classification. This technique has been previously described in the literature [2] . Use of the maximum rCBV for characterization of the TSITC ensures that the most perfused portion of a heterogeneous tumor is evaluated, reducing sampling errors. Curves were assessed out to 50 TRs on the time axis. A Yaxis value prior to the first pass bolus was chosen to represent the average of the baseline and compared to the final Y axis value at 50TRs. The portion of the curve following the first pass of contrast medium bolus was characterized as returning to a level within ± 10% of baseline with plateau (return to baseline Figure 1 ), overshooting at least 10% above baseline without plateau (T1-dominant contrast leakage; Figure 2 ), or failing to return to a level less than 10% below baseline (T2*-dominant contrast leakage; Figure 3 ). Inter-observer agreement was assessed using Cohen's kappa. Blinded consensus opinion was obtained in cases with discrepant curve classification, and the resulting TSITCs were compared with individual WHO tumor grade. TSITC results were also compared to the averaged rCBV maximum between the two observers. Histopathologic evaluation of surgical specimens for all tumors was performed by one of two board-certified neuropathologists who determined a diagnosis and assigned a WHO grade of I through IV.
A Chi-square test of independence was used to assess for potential significant differences between 1.5T and 3.0T, 30ms and 45ms TE, range of TR, and dexamethasone administration. Diagnostic accuracy was assessed for specific curve patterns.
Statistical analysis was performed using SPSS 21 (IBM Corp. Armonk, NY) and an online statistical calculator (Vassarstats, http://vassarstats.net/). The Chi-squared test for independence between 1.5T and 3.0T scanners (p=0.63), 30 and 45 TE (p=0.55), and TR range (p=0.14) failed to show significance indicating that the null hypothesis is not rejected, or, that leakage patterns are not dependent on the differences in magnet strength, TE or TR in our scanning parameters. Dexamethasone, however did show some significant (p=0.02) effect. Further Chi-squared analysis between tumors treated with dexamethasone (N=41) and without dexamethasone (N=22) showed a significant difference in all low grade tumors (p=0.03) but not with pilocytic astrocytomas (p=0.99), pilomyxoid astrocytomas (p=1.0) or both of the piloid tumors together (p=0.46). For high grade tumors, dexamethasone also did not show a significant effect (p=0.09).
RESULTS

Patient
All tumors
Among 38 low grade tumors, twenty-five had consensus classification of T1-dominant contrast leakage while thirteen had a consensus curve classification other than T1-dominant leakage-either return to baseline or T2*-dominant leakage. The 25 tumors with T1-dominant contrast leakage included: 15 pilocytic astrocytomas, six pilomyxoid astrocytomas, one low grade glioneuronal tumor, one WHO grade 2 ependymoma, one desmoplastic infantile ganglioglioma, and one choroid plexus papilloma. Tumors showing a consensus curve classification with T2*dominant leakage or return to baseline were predominantly high grade. Ten out of 15 tumors identified as having post-bolus curve with T2*-dominant leakage were high grade (positive predictive value, 0.67, 0.39 -0.87), and 15 out of 23 tumors with curves identified as returning to baseline were high grade (positive predictive value, 0.65, 0.43 -0.83). Combining T2* and return to baseline patterns for high grade tumor yielded high sensitivity (1.0, 0.83-1.0) and negative predictive value (1.0, 0.83-1.0) at the cost of specificity (0.66, 0.49-0.80). The most common high grade tumors such as medulloblastoma, anaplastic ependymoma, and glioblastoma had both T2* and baseline patterns. All three cases of atypical teratoid rhabdoid tumor showed a return to baseline pattern. Conversely, the most common low grade tumors such as pilocytic astrocytoma and pilomyxoid astrocytoma demonstrated predominantly T1-dominant leakage: 15/17 for pilocytic astrocytoma and 6/6 for pilomyxoid astrocytoma. One case out of three WHO II ependymomas showed T1-dominant leakage. For the diagnosis of pilocytic or pilomyxoid astrocytoma, a T1-dominant leakage pattern yields a high sensitivity (0.91, 0.70-0.98; negative predictive value, 0.95, 0.81-0.99) and specificity (0.90, 0.75-0.97; positive predictive value, 0.84, 0.63-0.95) [ Table 2 ].
An analysis of variance (ANOVA) showed no significant differences (p=0.11, F-ratio=2.32) between the means of the rCBV maximum for each leakage pattern (T1-dominant = 3.25 ± 3.3, Baseline = 3.25 ± 2.2, T2*-dominant =5 .18 ± 3.6). A T-test between the means of rCBV maximum for T1-dominant leakage (3.25 ± 3.3) and T2*-dominant combined with baseline leakage patterns (4.02 ± 2.93) also yielded no significant difference (p=0.33). Chi squared tests were performed for significant differences between WHO grade and TSITC leakage results. Grade I versus grade II tumors were not significant (p=0.38) nor was grade III versus grade IV tumors (p=0.93). Only high (III and IV) versus low grade (I and II) were significant (p<0.0001).
Dexamethasone group
Among the forty-one patients with tumors that received dexamethasone prior to DSC perfusion MRI, nineteen had consensus T1-dominant leakage, twelve had a consensus T2*-dominant leakage pattern, and ten had a consensus return to baseline pattern. All nineteen with a T1dominant leakage pattern were low grade tumors while five other low grade tumors had a leakage pattern other than T1-dominant leakage. Out of twelve tumors with T2*-dominant leakage, nine were high grade. Out of ten tumors with return to baseline pattern, eight were high grade. Thirteen out of fourteen pilocytic astrocytomas and three out of three pilomyxoid astrocytomas demonstrated T1-dominant leakage. Diagnostic accuracy for this cohort is summarized in table 2. Within the entire dexamethasone group, no significant differences were seen between magnet strengths (p=0.62), TE (p=0.32), or TR (p=0. 20) .
No Dexamethasone group
Among the twenty-two patients with tumors that did not receive dexamethasone prior to DSC perfusion MRI, six had a consensus T1-dominant leakage, three had a consensus T2*-dominant leakage, and thirteen had a consensus return to baseline pattern. All six tumors with a T1dominant leakage pattern were low grade tumors. Eight low grade tumors had a leakage pattern other than T1-dominant leakage. Out of three tumors with T2*-dominant leakage, only one was high grade. Out of thirteen tumors with return to baseline pattern, seven were high grade. Two out of three pilocytic astrocytomas and three out of three pilomyxoid astrocytomas demonstrated T1-dominant leakage. Diagnostic accuracy is summarized in table 2. Within the entire no dexamethasone group, no significant differences were seen between magnet strengths (p=0.08), TE (p=0.97), or TR (p=0.40).
DISCUSSION
In practice, hemodynamics, status of the blood-brain barrier, timing of the contrast bolus, and MR pulse sequence parameters affect the shape of the TSITC [12] [13] [14] [15] [16] . Disruption or lack of a blood-brain barrier results in leakage of contrast medium into the extravascular extracellular space. While in the intravascular space, paramagnetic contrast medium causes predominantly T2* effects with loss of MR signal, however once in the extravascular extracellular space, T1shortening effects compete with the T2* effects [15, 16] . Depending on the MR parameters and biological tissue environment, T1-shortening effects may predominate and cause a post bolus curve that returns to and then passes baseline, or T2* effects may predominate and result in a post bolus curve that fails to return to baseline [15] . Another mechanism for a curve that fails to return to baseline was suggested by Kassner et al who showed that residual T2* effects may reflect delayed passage of intravascular contrast medium due to vascular tortuosity, disorganization, and hypoperfusion in areas of increased neovascularity, comparing this effect to the tumor staining seen on catheter angiography [13] .
Previous authors describe the portion of the curve after the peak as percent signal recovery, [9, 17] with a high percent signal recovery correlating with our T1-dominant leakage, and a low percent signal recovery as T2*-dominant leakage, or with smaller T2* effects, a return to baseline. Cha et al. demonstrate a significant difference between metastatic brain tumors and glioblastoma as well as the associated surrounding abnormal white matter in adults with greater T2* effects and less than 50% return to baseline for metastatic tumors compared to greater than 75% recovery for glioblastoma. They suggest that this difference is due to the lack of a blood brain barrier leading to greater uniform vascular permeability and leakage in metastatic tumors, compared to some presence of a blood brain barrier in glioblastomas, with less uniform vascular permeability [15] . Lastly, the balance between T1 and T2* effects is affected by varying MR parameters including the flip angle, TE and TR in gradient echo EPI DSC perfusion MRI [10, 12, 13, 15, 16, 17] . We used a narrow range of TE for similar T2* effect across scanners and a uniform flip angle on all scanners for recovery from the peak. Previous authors have used a low flip angle to suppress T1 signal effects [16, 17] ; however in our study, our 90 degree flip angle does not sufficiently suppress the T1 signal for our range of TR to prevent overshoot of the baseline in most low grade tumors, which we categorized as T1-dominant leakage.
Advances in knowledge
A striking finding in our data was 100% positive predictive value (25 of 25) for low grade tumors if a T1-dominant leakage pattern was identified. The converse is also true in that the lack of a T1 leak pattern (T2* or return to baseline) results in a 100% negative predictive value for high grade tumors. T1-dominant leakage patterns were also sensitive and specific for either a pilocytic astrocytoma or pilomyxoid astrocytoma. In addition, good interobserver agreement for identifying a T1-dominant leakage pattern was found, indicating significant potential clinical utility for grading pediatric brain tumors with TSITCs from DSC perfusion.
Little prior data exists in the literature regarding the use of DSC perfusion MRI and signal intensity curves in the evaluation of pediatric brain tumors. Similar to our findings, Grand et al reported a series of 9 pilocytic astrocytomas evaluated with DSC perfusion MRI, in which all 9 tumors demonstrated an overshoot of the baseline, or T1-dominant contrast leakage pattern [16] . Cha reported that pilocytic astrocytomas have > 70% signal recovery, while medulloblastomas have < 50% signal recovery, which is consistent with our findings [18] .
Prior to our study, a T1-dominant leakage pattern has most notably been demonstrated in primary CNS lymphoma, and has been shown to be useful in distinguishing lymphoma from glioblastoma multiforme and CNS metastases [9] [10] [11] . Despite the lack of neoangiogenesis in CNS lymphoma, both glioblastoma and lymphoma have elevated rCBV, but have a significant difference in the high percent signal recovery for lymphomas. This has been attributed to the characteristic perivascular invasion of lymphoma cells, leading to disruption of the basement membrane and resulting vascular permeability. The hypercellularity of lymphoma with a small extravascular extracellular space has been suggested as a contributing factor although the exact mechanism for T1-dominant leakage effects in lymphoma is not well understood [9] . This finding contradicts the findings of Cha et al. in that the lack of a blood brain barrier in metastatic disease, with resulting vascular permeability results in a low percent recovery, or T2*-dominant effect rather than the T1-dominant effect in CNS lymphoma [9, 17] . Cha et al. used a flip angle of 35° compared to 80° for Mangla et al., which may contribute to the differing TSITC results. Biological factors may include differing rates of contrast leakage between CNS lymphoma and metastatic disease with a faster accumulation and concentration of extravascular contrast in metastatic disease leading to T2*-dominant effects. The mechanism underlying the observed post-bolus T1-dominant effects in low-grade pediatric brain tumors is not known, but is also likely related to the balance between T1-shortening and T2* effects of paramagnetic contrast medium that has leaked into the extravascular extracellular space. Other factors affecting the T1-T2* balance may include characteristics of the extravascular space such as cellular density, water content, and other molecular constituents, in addition to hemodynamic flow issues and capillary permeability.
Pilocytic astrocytomas and pilomyxoid astrocytomas account for 21 of the 25 tumors in our series demonstrating post-bolus T1-dominant leakage. Pilocytic astrocytomas are described as having biphasic histology with areas of loose glial tissue interposed with compacted piloid tissue composed of dense hypercellular sheets of elongated bipolar cells [20] . Distinguishing features of pilomyxoid astrocytomas include monomorphous piloid cells in a myxoid background with an angiocentric pattern, similar to perivascular pseudorosettes in ependymomas. While pilomyxoid astrocytomas tend to occur in younger children in the hypothalamic/ chiasmatic pathway, with more aggressive behavior, and a higher propensity for leptomeningeal spread, pilocytic and pilomyxoid astrocytomas have significant morphological and imaging overlap. There have been reports of recurrent pilomyxoid tumors demonstrating pilocytic features after several years, with some authors suggesting that pilomyxoid astrocytoma may be an infantile form versus an extreme subtype of pilocytic astrocytoma [21] [22] [23] . It is because of this significant overlap, and the lack of distinguishing imaging characteristics between the two tumors that we calculated diagnostic accuracy with both tumors rather than separately. Vascular proliferation can be seen in the solid component of both tumors but with more mature endothelial cells in a single layer compared to glioblastomas [24, 25] . These single endothelial layers with open tight junctions and fenestrae as well as hyaline degeneration around vessels have been postulated to allow contrast medium extravasation and therefore vascular permeability [18] . Similar to CNS lymphomas, this level of increased vascular permeability likely plays a partial but crucial role in the T1-dominant leakage effects seen in both tumors. Further research between different pediatric tumors using T1 signal based dynamic contrast enhancement MRI may be helpful in elucidating differences in vascular permeability.
Affect of Dexamethasone on leakage patterns
We could not control for the administration of dexamethasone on newly diagnosed brain tumor pediatric patients as corticosteroids are a first line emergent therapy for controlling the cerebral swelling and the resultant mass effect from mass occupying brain tumors. In a previous work on the same patient population, there was no significance between patients with and without dexamethasone treatment and rCBV measurements [2] . However, given the known rapid effects of dexamethasone in decreasing capillary permeability and reducing vasogenic edema [26, 27] , the significance between patient populations is not surprising. However, only our low grade tumor group was significant, and there was larger proportion of T1-dominant and T2*-dominant leakage patterns within the dexamethasone group. This result seems counterintuitive as high grade tumors typically have greater vasogenic edema and mass effect, and decreasing capillary permeability should trend toward the return to baseline pattern, as this pattern would best represent no leakage. In reality, multiple physiological parameters likely affect the leakage pattern as indicated by our results. Despite the significance of dexamethasone on the low grade tumor group, the 100% specificity of a T1-dominant leakage pattern for low grade pediatric tumors and high sensitivity and specificity for piloid astrocytomas remain unchanged for both groups with or without dexamethasone.
Implications for patient care
Despite uncertainty in the exact underlying mechanism, a T1-dominant contrast leakage pattern on the signal intensity curve obtained in the region of highest tumor rCBV is empirically highly predictive for low grade brain tumor in the pediatric population, while a T2*-dominant or baseline pattern has high sensitivity for a high grade tumor. In addition to rCBV data [2] , TSITCs from DSC perfusion potentially offers additional information not otherwise apparent with routine anatomic MRI sequences. Recognition of a T1-dominant leakage pattern may improve accuracy in preoperatively predicting the presence of a low grade pediatric brain tumor. While experienced pediatric neuroradiologists can recognize low versus high grade tumors in the majority of cases, recognition of this pattern of perfusion leakage may be highly helpful in the minority of cases where low grade pilocytic or pilomyxoid astrocytomas become large and heterogeneous, mimicking higher grade neoplasms and conversely, when high grade astrocytomas have benign imaging features (Figures 1, 2 ). Furthermore, when complete surgical resection is not possible, knowing the likelihood of a high grade or low grade tumor can guide how aggressive a neurosurgeon should be in debulking the tumor, at the risk of significant morbidity and mortality.
Limitations
The neuroradiologists evaluating the perfusion data were not blinded to the anatomic MRI sequences, some of which were highly suggestive of the tumor diagnosis. This was unavoidable because the anatomic images provide information integral in the assessment of the perfusion images (e.g. location of tumor, location of major vessels, etc.) This limitation is reasonable however, because it reflects the process in which MR perfusion images are evaluated in clinical practice. As noted in the discussion, a T1-dominant contrast leakage pattern has been described in CNS lymphoma and our series of 63 pediatric brain tumors included no cases of CNS lymphoma. While this represents a potential pitfall in using a T1-dominant leakage pattern to classify pediatric brain tumors as low grade, CNS lymphoma is rarely encountered in the pediatric population. Contrast medium infusion rate and peripheral intravenous catheter gauge are related issues that likely affect the quality of the perfusion study and are recognized challenges with performing DSC perfusion MRI on pediatric patients [28] . However, only one study out of the 65 identified by the search criteria was excluded for poor contrast medium bolus, indicating that high quality DSC perfusion MRI can be performed in pediatric brain tumor patients. Differences in TR and TE parameters corresponded to studies obtained on different 1.5T and 3.0T scanners and theoretically has some effect on signal intensity and recovery/leakage patterns. However, our analysis demonstrates no significant differences in our results attributable to these different field strengths or parameters. It is important to note that there is no standardized criteria in the literature for T1 leak/T2* leak, or return to baseline. We arbitrarily chose the +/-10% range for the curve classification as a means of separation, and consequently curve classification could be altered if different thresholds are utilized. Similarly, as previously described, larger differences in technical parameters (flip angle, TE, TR) may result in greater differences in curve classification.
CONCLUSIONS
There is good interobserver agreement in classification of DSC perfusion tissue signal intensity time curves for pediatric brain tumors. Among our population of pediatric brain tumor patients, a T1-dominant leakage pattern is 100% specific for a low grade tumor and sensitive and specific for piloid astrocytomas, regardless of dexamethasone treatment. The addition of tissue signal intensity time curves may help in cases where low grade tumors are large and heterogeneous, mimicking high grade neoplasms. The tumor has T2 hyperintensity, cystic change, minimal heterogeneous enhancement and has well circumscribed margins suggesting a low grade neoplasm such as a pilocytic astrocytoma. However, the TSITC from a ROI with the highest tumoral rCBV demonstrates a return to baseline pattern, which is highly sensitive for a high grade tumor, and low probability that this represents a pilocytic or pilomyxoid astrocytoma. 
